Livforsakringsbolaget Skandia’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24M Buy
68,130
+10,752
+19% +$3.83M 0.93% 23
2025
Q4
$18.8M Sell
57,378
-240
-0.4% -$76.1K 0.73% 30
2025
Q3
$16.3M Buy
57,618
+1,400
+2% +$406K 0.64% 37
2025
Q2
$15.7M Buy
56,218
+9,200
+20% +$2.61M 0.68% 30
2025
Q1
$14.6M Sell
47,018
-200
-0.4% -$59.1K 0.83% 23
2024
Q4
$12.3M Sell
47,218
-100
-0.2% -$29.7K 0.65% 28
2024
Q3
$15.2M Buy
47,318
+11,954
+34% +$3.91M 0.82% 22
2024
Q2
$11M Sell
35,364
-400
-1% -$118K 0.9% 20
2024
Q1
$10.2M Buy
35,764
+1,000
+3% +$293K 0.86% 23
2023
Q4
$10M Buy
34,764
+568
+2% +$155K 0.96% 17
2023
Q3
$9.19M Buy
34,196
+700
+2% +$175K 1.01% 16
2023
Q2
$7.44M Sell
33,496
-3,400
-9% -$789K 0.77% 29
2023
Q1
$8.92M Hold
36,896
0.93% 23
2022
Q4
$9.69M Hold
36,896
1.11% 15
2022
Q3
$8.32M Sell
36,896
-7,800
-17% -$1.89M 1.03% 18
2022
Q2
$10.9M Sell
44,696
-1,800
-4% -$441K 0.95% 23
2022
Q1
$11.2M Hold
46,496
0.75% 29
2021
Q4
$10.5M Sell
46,496
-2,800
-6% -$591K 0.66% 31
2021
Q3
$10.5M Sell
49,296
-1,100
-2% -$253K 0.66% 30
2021
Q2
$12.3M Buy
50,396
+3,200
+7% +$787K 0.73% 27
2021
Q1
$11.7M Buy
47,196
+5,900
+14% +$1.41M 0.82% 23
2020
Q4
$9.49M Buy
41,296
+2,400
+6% +$553K 0.81% 26
2020
Q3
$9.89M Sell
38,896
-400
-1% -$99.1K 1.06% 17
2020
Q2
$9.27M Hold
39,296
1.06% 17
2020
Q1
$7.97M Buy
39,296
+1,700
+5% +$371K 1.12% 16
2019
Q4
$9.06M Sell
37,596
-2,400
-6% -$529K 1.08% 15
2019
Q3
$7.74M Hold
39,996
0.92% 23
2019
Q2
$7.37M Buy
39,996
+800
+2% +$143K 0.9% 22
2019
Q1
$7.45M Buy
39,196
+500
+1% +$95.5K 0.98% 18
2018
Q4
$7.53M Hold
38,696
1.13% 15
2018
Q3
$8.02M Sell
38,696
-12,600
-25% -$2.48M 0.95% 17
2018
Q2
$9.47M Buy
51,296
+800
+2% +$142K 0.86% 22
2018
Q1
$8.61M Sell
50,496
-8,200
-14% -$1.51M 0.83% 23
2017
Q4
$10.2M Sell
58,696
-3,600
-6% -$637K 0.98% 18
2017
Q3
$11.6M Sell
62,296
-2,556
-4% -$453K 1.04% 16
2017
Q2
$11.2M Hold
64,852
1.03% 19
2017
Q1
$10.6M Sell
64,852
-28,300
-30% -$4.7M 1% 17
2016
Q4
$13.6K Buy
93,152
+59,649
+178% +$8.98M 0.69% 25
2016
Q3
$2.12M Sell
33,503
-84,672
-72% -$14.3M 0.1% 267
2016
Q2
$18M Buy
118,175
+11,130
+10% +$1.73M 0.8% 23
2016
Q1
$16M Buy
107,045
+14,100
+15% +$2.09M 0.75% 26
2015
Q4
$15.1M Buy
92,945
+5,500
+6% +$865K 0.71% 30
2015
Q3
$12.1M Buy
87,445
+700
+0.8% +$110K 0.64% 32
2015
Q2
$13.3M Buy
86,745
+5,079
+6% +$814K 0.65% 31
2015
Q1
$13.1M Buy
81,666
+4,100
+5% +$646K 0.64% 30
2014
Q4
$12.4M Sell
77,566
-32,100
-29% -$5M 0.58% 33
2014
Q3
$15.4M Sell
109,666
-11,600
-10% -$1.51M 0.58% 33
2014
Q2
$14.4M Buy
121,266
+3,400
+3% +$394K 0.52% 38
2014
Q1
$14.5M Buy
117,866
+111,466
+1,742% +$13.5M 0.55% 36
2013
Q4
$730K Hold
6,400
0.47% 80
2013
Q3
$716K Buy
6,400
+4,400
+220% +$477K 0.5% 76
2013
Q2
$197K Buy
+2,000
New +$208K 0.14% 138

Other funds holding AMGN

Livforsakringsbolaget Skandia's AMGN Position: Q1 2026 in Review

Livforsakringsbolaget Skandia increased its Amgen (AMGN) stake by 19% in Q1 2026, buying an estimated $3.83M and bringing the position to 68,130 shares worth $24M. The position accounts for 0.93% of the portfolio, ranked #23.

Livforsakringsbolaget Skandia first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,137 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Livforsakringsbolaget Skandia held 68,130 shares of Amgen worth $24M as of Q1 2026.
  • Livforsakringsbolaget Skandia bought 10,752 Amgen shares in Q1 2026, an estimated $3.83M.
  • Amgen made up 0.93% of Livforsakringsbolaget Skandia's portfolio in Q1 2026, its #23 holding.
  • Livforsakringsbolaget Skandia first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • 3,137 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Livforsakringsbolaget Skandia's 13F filing for Q1 2026, filed 5 May 2026.